CN Patent

CN106117182B — 喹唑啉-n-苯乙基四氢异喹啉类化合物及其制备方法和应用

Assigned to China Pharmaceutical University · Expires 2019-08-30 · 7y expired

What this patent protects

本发明涉及通式(I)化合物及其盐，这类化合物有较强的逆转肿瘤多药耐药(MDR)作用，部分化合物活性远高于维拉帕米，并且具有较小的细胞毒性，本发明还涉及含有它们的药物制剂。本发明合成了一系列通式(I)化合物及其药学上可接受的盐。

USPTO Abstract

本发明涉及通式(I)化合物及其盐，这类化合物有较强的逆转肿瘤多药耐药(MDR)作用，部分化合物活性远高于维拉帕米，并且具有较小的细胞毒性，本发明还涉及含有它们的药物制剂。本发明合成了一系列通式(I)化合物及其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN106117182B
Jurisdiction
CN
Classification
—
Expires
2019-08-30
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.